Dexpol Neo Multitrades Private Limited

Dexpol Neo Multitrades Private Limited - chemicals in Petlawad, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U24290MP2022PTC062183 Incorporated 10 August 2022 ROC Gwalior HQ Petlawad, Madhya Pradesh, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2024
₹44,917
▲ 3175% YoY
Net loss · FY 2024
₹13,943
Net margin -31%
EBITDA · FY 2024
-₹13,928
EBITDA margin -31%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹100
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Last financials
Mar 2024
Balance sheet date

About Dexpol Neo Multitrades Private Limited

Data last updated:

Dexpol Neo Multitrades Private Limited is a private limited company based in Petlawad, Madhya Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 10 August 2022.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2022PTC062183.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹100. It is led by directors Neeta Purohit and Naresh Sharma.

Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Shankar Lal Babulal Chawda Bamaniya Road, Petlawad, Madhya Pradesh, India – 457773.

As per the financials filed for FY 2024, the company reported a revenue of ₹44,917, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13,943 (net margin -31%) and EBITDA of -₹13,928 (EBITDA margin -31%).

Dexpol Neo Multitrades Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-25-0003394).

Company details

CIN U24290MP2022PTC062183
Registration Number 062183
Incorporation Date 10 August 2022
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MP-25-0003394

Recognitions & Rankings of Dexpol Neo Multitrades

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-25-0003394

Contact details

Dexpol Neo Multitrades Private Limited's registered office is in Petlawad, Madhya Pradesh.

  • Registered Address
    C/O Shankar Lal Babulal Chawda Bamaniya Road, Petlawad, Madhya Pradesh, India – 457773
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Dexpol Neo Multitrades Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Dexpol Neo Multitrades is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Dexpol Neo Multitrades Private Limited, buy the company report.

Financials of Dexpol Neo Multitrades Private Limited

FY 2024 filings available

Dexpol Neo Multitrades Private Limited reported revenue of ₹44,917 (up 3175% YoY) for FY 2024.

Revenue · FY 2024
₹44,917 ▲ 3175%
Net loss · FY 2024
₹13,943 margin -31%
EBITDA · FY 2024
-₹13,928 margin -31%

Financial Statement Summary

MetricsFY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹13,928
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹13,943
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23
Profitability
EBITDA Margin-31%
Net Profit Margin-31%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dexpol Neo Multitrades Private Limited, buy the company report.

Board of directors of Dexpol Neo Multitrades Private Limited

Dexpol Neo Multitrades has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Neeta PurohitDirector11 Jun 20242 Years 4 MonthsCurrent
Naresh SharmaDirector20 Feb 20251 Years 8 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dexpol Neo Multitrades Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Dexpol Neo Multitrades Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Dexpol Neo Multitrades Private Limited has 7 board changes on record since 2024: 3 appointments and 4 cessations. The latest: Naresh Sharma was appointed as Director on 20 Feb 2025.

Appointed
Naresh Sharma was appointed as Director.
Ceased
Kapil Das Bairagi ceased to be Director.
Ceased
Balkrishn Gamad ceased to be Additional Director.
Ceased
Mahesh Kumar Purohit ceased to be Director.
Ceased
Neeta Purohit ceased to be Additional Director.
AGM
Dexpol Neo Multitrades Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Appointed
Balkrishn Gamad was appointed as Director.
Appointed
Neeta Purohit was appointed as Director.
Filing
Dexpol Neo Multitrades Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior.
Incorporation
10 Aug 2022
Dexpol Neo Multitrades Private Limited was registered on 10 Aug 2022 with Roc Gwalior & aged 4 years 2 months as per MCA records.

Frequently asked questions

Dexpol Neo Multitrades is an active private limited company based in Petlawad, Madhya Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 10 August 2022 (4+ years old) and is registered under CIN U24290MP2022PTC062183.

Dexpol Neo Multitrades has 2 current directors:

The latest financial statements of Dexpol Neo Multitrades on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2023 are in the company report.

The CIN (Corporate Identification Number) of Dexpol Neo Multitrades is U24290MP2022PTC062183. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dexpol Neo Multitrades was incorporated on 10 August 2022, making it 4+ years old. It is registered with the Registrar of Companies, Gwalior.

Naresh Sharma was appointed as Director on 20 Feb 2025. Kapil Das Bairagi ceased to be Director on 06 Nov 2024. Balkrishn Gamad ceased to be Additional Director on 04 Nov 2024. Dexpol Neo Multitrades has 7 board changes on record in total.

Yes, Dexpol Neo Multitrades is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-25-0003394).

The registered office of Dexpol Neo Multitrades is at CO Shankar Lal Babulal Chawda Bamaniya Road, Petlawad, Madhya Pradesh, India – 457773.

Dexpol Neo Multitrades operates in the chemicals industry, in the manufacturing segment.

Dexpol Neo Multitrades can be reached at its registered office: CO Shankar Lal Babulal Chawda Bamaniya Road, Petlawad, Madhya Pradesh, India – 457773.